CIK 0001756262
- Large accelerated filer
TransMedics Group, Inc.
Sign in to watch- Ticker
- TMDX
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- Operating
- Phone
- +1 978-552-0900
- Business address
- 200 MINUTEMAN ROAD, ANDOVER, MA, 01810
- 4 Open-market sale Chief Commercial Officer sold 3,941 shares at $35.08 ($138,250)
- 4 Open-market sale Chief Financial Officer sold 10,000 shares at $35.00 ($350,000)
- 4 Open-market sale VP of Operations sold 1,680 shares at an average $31.98 ($53,734)
- 4 Exercise or conversion VP of Quality & Engineering acquired 3,200 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale VP of Operations sold 1,680 shares at $28.33 ($47,594)
- 4 Exercise or conversion VP of US Regulatory & FDA Rel. acquired 2,206 shares (option exercise)
- 4 Open-market sale Chief Commercial Officer sold 5,152 shares at $35.10 ($180,835)
- 4 Open-market sale Chief Financial Officer sold 10,000 shares at $35.00 ($350,000)
- 4 Open-market sale VP of Operations sold 1,680 shares at an average $33.65 ($56,538)
- 4 Open-market sale Chief Commercial Officer sold 3,899 shares at $35.06 ($136,699)
- 4 Open-market sale Chief Financial Officer sold 10,000 shares at $30.00 ($300,000)
- 4 Exercise or conversion Chief Financial Officer acquired 5,714 shares (option exercise)
- 4 Open-market sale VP of Operations sold 1,680 shares at $26.01 ($43,697)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 13 of 18 · 358 filings